AU4951497A - Use of antagonists of substance p for treating tardive diskinesia - Google Patents

Use of antagonists of substance p for treating tardive diskinesia

Info

Publication number
AU4951497A
AU4951497A AU49514/97A AU4951497A AU4951497A AU 4951497 A AU4951497 A AU 4951497A AU 49514/97 A AU49514/97 A AU 49514/97A AU 4951497 A AU4951497 A AU 4951497A AU 4951497 A AU4951497 A AU 4951497A
Authority
AU
Australia
Prior art keywords
antagonists
substance
tardive diskinesia
treating tardive
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU49514/97A
Other languages
English (en)
Inventor
Olivier Gobbo
Assunta Imperato
Saliha Moussaoui
Carmen Obinu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Rhone Poulenc Rorer SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer SA filed Critical Rhone Poulenc Rorer SA
Publication of AU4951497A publication Critical patent/AU4951497A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/4035—Isoindoles, e.g. phthalimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4418—Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AU49514/97A 1996-10-29 1997-10-24 Use of antagonists of substance p for treating tardive diskinesia Abandoned AU4951497A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9613175A FR2755013B1 (fr) 1996-10-29 1996-10-29 Nouvelle application therapeutique des antagonistes de la substance p
FR9613175 1996-10-29
PCT/FR1997/001914 WO1998018465A1 (fr) 1996-10-29 1997-10-24 Utilisation des antagonistes de la substance p pour le traitement des dyskinesies tardives

Publications (1)

Publication Number Publication Date
AU4951497A true AU4951497A (en) 1998-05-22

Family

ID=9497133

Family Applications (1)

Application Number Title Priority Date Filing Date
AU49514/97A Abandoned AU4951497A (en) 1996-10-29 1997-10-24 Use of antagonists of substance p for treating tardive diskinesia

Country Status (3)

Country Link
AU (1) AU4951497A (fr)
FR (1) FR2755013B1 (fr)
WO (1) WO1998018465A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0942732B1 (fr) * 1996-12-02 2004-11-17 MERCK SHARP & DOHME LTD. Utilisation d'antagonistes du recepteur nk-1 dans le traitement des diskynesies
US6156749A (en) * 1997-12-01 2000-12-05 Merck Sharp & Dohme Limited Use of NK-1 receptor antagonists for treating movement disorders
RU2278612C2 (ru) 2000-07-14 2006-06-27 Лайфскен, Инк. Иммуносенсор
US20060134713A1 (en) 2002-03-21 2006-06-22 Lifescan, Inc. Biosensor apparatus and methods of use

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2654726B1 (fr) * 1989-11-23 1992-02-14 Rhone Poulenc Sante Nouveaux derives de l'isoindolone et leur preparation.
US5216018A (en) * 1992-02-14 1993-06-01 Du Pont Merck Pharmaceutical Company Hydroisoindolines and hydroisoquinolines as psychotropic
EP0634402A1 (fr) * 1993-07-14 1995-01-18 Takeda Chemical Industries, Ltd. Dérivés d'isoquinolinone, leur production et utilisation
US5541217A (en) * 1995-05-17 1996-07-30 Ortho Pharmaceutical Corporation 4-arylcyclopenta[c]pyrrole analgesics

Also Published As

Publication number Publication date
WO1998018465A1 (fr) 1998-05-07
FR2755013B1 (fr) 1998-11-27
FR2755013A1 (fr) 1998-04-30

Similar Documents

Publication Publication Date Title
AU3813397A (en) Apparatus for treating chondromalicia
AU2060097A (en) Massaging apparatus
AU6449798A (en) Apparatus and methods for the preparation of chemical compounds
AU3824997A (en) Apparatus for tissue remodeling
AU8851898A (en) An apparatus for tissue treatment
AU2917497A (en) Surgical apparatus
AU3497297A (en) Roller-ski apparatus
AU2723297A (en) Scintillator apparatus
AU4347097A (en) Apparatus for tissue preparation
AU7368798A (en) Tissue analysis apparatus
AU5427398A (en) Cytoperfusion of tissue specimens
AU8068198A (en) Methods for treating human cancers
AU1733997A (en) Blower-vacuum apparatus
AU5702698A (en) Polyprolyl inhibitors of cyclophilin
AU1081897A (en) Heterocyclic compounds and their use
AU4951497A (en) Use of antagonists of substance p for treating tardive diskinesia
AU2152497A (en) Heterocyclic compounds and their preparation and use
AU8809098A (en) Procedure and apparatus for the treatment of waste
AU3046997A (en) Electro-medical apparatus
AU2595297A (en) Use of aminoalkylcarboxylic derivatives
AU2987097A (en) De-wiring apparatus
AU5855098A (en) Use of polypeptides for treating thrombocytopenia
AU1141497A (en) Heterocyclic compounds and their use
AU4310397A (en) Treatment of waste
AU1794397A (en) Use of alpha1-adrenoceptor antagonists